頭部外傷の治療(交通事故による脳障害,第48回千葉医学会学術大会,第17回千葉県医師会学術大会,第10回日医医学講座,連合大会)

BACKGROUND:The negative consequences of energy dense foods are well known, yet people increasingly make unhealthy food choices leading to obesity (i.e., risky decisions). The aims of this study were: [1] to compare performance in decision-making tasks under risk and under ambiguity between individuals with obesity, overweight and normal weight; [2] to examine the associations between body mass index (BMI) and decision-making, and the degree to which these associations are modulated by reward sensitivity. METHODS:Seventy-nine adults were recruited and classified in three groups according to their BMI: obesity, overweight and normal-weight. Groups were similar in terms of age, education and socio-economic status, and were screened for comorbid medical and mental health conditions. Decision-making under risk was measured via the Wheel of Fortune Task (WoFT) and decision-making under ambiguity via the Iowa Gambling Task (IGT). Reward sensitivity was indicated by the Sensitivity to Punishment and Sensitivity to Reward Questionnaire (SPSRQ). RESULTS:Individuals with obesity made riskier choices in the WoFT, specifically in choices with an expected value close to zero and in the propensity to risk index. No differences were found in IGT performance or SPSRQ scores. BMI was associated with risk-taking (WoFT performance), independently of reward sensitivity. CONCLUSIONS:Obesity is linked to a propensity to make risky decisions in experimental conditions analogous to everyday food choices

Altered decision-making under risk in obesity

Background: The negative consequences of energy dense foods are well known, yet people increasingly make unhealthy food choices leading to obesity (i.e., risky decisions). The aims of this study were: [1] to compare performance in decision-making tasks under risk and under ambiguity between individuals with obesity, overweight and normal weight; [2] to examine the associations between body mass index (BMI) and decision-making, and the degree to which these associations are modulated by reward sensitivity. Methods: Seventy-nine adults were recruited and classified in three groups according to their BMI: obesity, overweight and normal-weight. Groups were similar in terms of age, education and socio-economic status, and were screened for comorbid medical and mental health conditions. Decision-making under risk was measured via the Wheel of Fortune Task (WoFT) and decision-making under ambiguity via the Iowa Gambling Task (IGT). Reward sensitivity was indicated by the Sensitivity to Punishment and Sensitivity to Reward Questionnaire (SPSRQ). Results: Individuals with obesity made riskier choices in the WoFT, specifically in choices with an expected value close to zero and in the propensity to risk index. No differences were found in IGT performance or SPSRQ scores. BMI was associated with risk-taking (WoFT performance), independently of reward sensitivity. Conclusions: Obesity is linked to a propensity to make risky decisions in experimental conditions analogous to everyday food choices

Research network on interoperability of applications and software for networked enterprises in the Valencian Region (INTERVAL)

Enterprise interoperability is a tool for enhancing the competitiveness of firms, and its importance is brought out by the fact one of the EC’s strategic aims is to accomplish interoperability among European firms by the year 2010. Nevertheless, in the particular case of the Valencian Region (Spain), research into enterprise interoperability is still badly structured, fragmented, overlapping and, in many cases, practically non-existent. The INTERVAL project has been set up in an attempt to solve this problem. The scheme plans to carry out a series of initiatives aimed at integrating research activities and applying them to the complicated Valencian business sector. By so doing these companies would benefit from the application of knowledge created specifically for them and adapted to fit their characteristics. In this paper we present the details of the project, including its goals, aims, activities, results achieved, the methodology used to accomplish them, the economic and/or technological advantages, as well as possible applications and future lines of research

Actualizaciones sobre declaraciones nutricionales y de propiedades saludables

There is concern about the influence of social determinants related to advertising, communication and information on the selection of food for healthy eating and safe. From this point of view, Spain created the European Regulation 1924/2006 (ER1924/2006), its aim is to ensure and promote access to safe food that benefit health and prevent information received by consumers is inaccurate, ambiguous or misleading. The aims of regulation are to prevent nutritional and attributed health claims to food without reason or if there is sufficient scientific evidence. In this sense, a group of professionals from the University of Alicante in December 2012 performed the First Day of Food and Nutrition, organized by the Center Alinua of the Faculty of Health Sciences, University of Alicante, related to updates on nutrition and health claims and its implications public health.By the interest and importance of this topic, this is a summary of the position papers from agents involved: consumers, government, food business, the gremial’s dietitian, the Academy and public health.Existe preocupación por la influencia de los determinantes sociales relacionados con la publicidad, la comunicación y la información sobre la selección de productos alimenticios para conseguir una alimentación saludable y segura. Desde este punto de vista, la legislación española normaliza este aspecto, a través del Reglamento Europeo 1924/2006 (RE1924/2006). El objetivo es asegurar y favorecer el acceso a alimentos inocuos que beneficien la salud y, evitar que la información recibida por los consumidores sea inexacta, ambigua o engañosa. El Reglamento pretende impedir que se atribuyan propiedades nutritivas y declaraciones de propiedades saludables a los alimentos sin razón o sin que exista suficiente evidencia científica. En este sentido, un grupo de profesionales de la Universidad de Alicante en diciembre de 2012 llevó a cabo la Primera Jornada de Alimentación y Nutrición, organizada por el Gabinete ALINU de la Facultad de Ciencias de la Salud de la Universidad de Alicante, relacionada con actualizaciones sobre declaraciones nutricionales y de propiedades saludables y sus implicaciones en la salud pública.Por el interés y la importancia del tema, se presenta un resumen de las ponencias desde la postura de los diferentes agentes implicados: consumidores, Administración, industria alimentaria, dietistas-nutricionistas, la Academia y la Salud Pública

Protocolo del servicio para la realización, trazabilidad y seguimiento de los resultados obtenidos de test de diagnóstico y autodiagnóstico de antígenos de SARS-CoV-2

Introducción: A través de un acuerdo de colaboración entre el Departamento de Sanidad del Gobierno de Aragón y el Consejo de Colegios Oficiales de Farmacéuticos de Aragón, las oficinas de farmacia de Aragón tienen la posibilidad de adherirse voluntariamente para su colaboración en la vigilancia epidemiológica, mediante la realización de test de antígenos, comunicación de los resultados y emisión de certificados. Método: Previamente a la adhesión, las farmacias han de cumplir una serie de requisitos, incluyendo una declaración de responsabilidad. Ante la solicitud de un paciente asintomático que desea realizarse un test, el farmacéutico debe seguir un algoritmo de decisión. Resultados: A fecha 3 de octubre de 2021,303 farmacias en Aragón han participado. Se han emitido 6.021 Certificados COVID Digitales de la UE, tras la realización de un test de diagnóstico de antígenos en la oficina de farmacia, con 92 resultados positivos.  Conclusiones: Las oficinas de farmacia han resultado esenciales en la realización de test de antígenos, comunicación de resultados y emisión de Certificados COVID Digitales de la UE

Protocolo del servicio para la realización, trazabilidad y seguimiento de los resultados obtenidos de test de diagnóstico y autodiagnóstico de antígenos de SARS-CoV-2

Introducción: A través de un acuerdo de colaboración entre el Departamento de Sanidad del Gobierno de Aragón y el Consejo de Colegios Oficiales de Farmacéuticos de Aragón, las oficinas de farmacia de Aragón tienen la posibilidad de adherirse voluntariamente para su colaboración en la vigilancia epidemiológica, mediante la realización de test de antígenos, comunicación de los resultados y emisión de certificados. Método: Previamente a la adhesión, las farmacias han de cumplir una serie de requisitos, incluyendo una declaración de responsabilidad. Ante la solicitud de un paciente asintomático que desea realizarse un test, el farmacéutico debe seguir un algoritmo de decisión. Resultados: A fecha 3 de octubre de 2021,303 farmacias en Aragón han participado. Se han emitido 6.021 Certificados COVID Digitales de la UE, tras la realización de un test de diagnóstico de antígenos en la oficina de farmacia, con 92 resultados positivos.  Conclusiones: Las oficinas de farmacia han resultado esenciales en la realización de test de antígenos, comunicación de resultados y emisión de Certificados COVID Digitales de la UE

Early dysfunction of functional connectivity in healthy elderly with subjective memory complaints

It is still an open question whether subjective memory complaints (SMC) can actually be considered to be clinically relevant predictors for the development of an objective memory impairment and even dementia. There is growing evidence that suggests that SMC are associated with an increased risk of dementia and with the presence of biological correlates of early Alzheimer's disease. In this paper, in order to shed some light on this issue, we try to discern whether subjects with SMC showed a different profile of functional connectivity compared with subjects with mild cognitive impairment (MCI) and healthy elderly subjects. In the present study, we compare the degree of synchronization of brain signals recorded with magnetoencephalography between three groups of subjects (56 in total): 19 with MCI, 12 with SMC and 25 healthy controls during a memory task. Synchronization likelihood, an index based on the theory of nonlinear dynamical systems, was used to measure functional connectivity. Briefly, results show that subjects with SMC have a very similar pattern of connectivity to control group, but on average, they present a lower synchronization value. These results could indicate that SMC are representing an initial stage with a hypo-synchronization (in comparison with the control group) where the brain system is still not compensating for the failing memory networks, but behaving as controls when compared with the MCI subjects

Effectiveness of an intervention for improving drug prescription in primary care patients with multimorbidity and polypharmacy:Study protocol of a cluster randomized clinical trial (Multi-PAP project)

This study was funded by the Fondo de Investigaciones Sanitarias ISCIII (Grant Numbers PI15/00276, PI15/00572, PI15/00996), REDISSEC (Project Numbers RD12/0001/0012, RD16/0001/0005), and the European Regional Development Fund ("A way to build Europe").Background: Multimorbidity is associated with negative effects both on people's health and on healthcare systems. A key problem linked to multimorbidity is polypharmacy, which in turn is associated with increased risk of partly preventable adverse effects, including mortality. The Ariadne principles describe a model of care based on a thorough assessment of diseases, treatments (and potential interactions), clinical status, context and preferences of patients with multimorbidity, with the aim of prioritizing and sharing realistic treatment goals that guide an individualized management. The aim of this study is to evaluate the effectiveness of a complex intervention that implements the Ariadne principles in a population of young-old patients with multimorbidity and polypharmacy. The intervention seeks to improve the appropriateness of prescribing in primary care (PC), as measured by the medication appropriateness index (MAI) score at 6 and 12months, as compared with usual care. Methods/Design: Design:pragmatic cluster randomized clinical trial. Unit of randomization: family physician (FP). Unit of analysis: patient. Scope: PC health centres in three autonomous communities: Aragon, Madrid, and Andalusia (Spain). Population: patients aged 65-74years with multimorbidity (≥3 chronic diseases) and polypharmacy (≥5 drugs prescribed in ≥3months). Sample size: n=400 (200 per study arm). Intervention: complex intervention based on the implementation of the Ariadne principles with two components: (1) FP training and (2) FP-patient interview. Outcomes: MAI score, health services use, quality of life (Euroqol 5D-5L), pharmacotherapy and adherence to treatment (Morisky-Green, Haynes-Sackett), and clinical and socio-demographic variables. Statistical analysis: primary outcome is the difference in MAI score between T0 and T1 and corresponding 95% confidence interval. Adjustment for confounding factors will be performed by multilevel analysis. All analyses will be carried out in accordance with the intention-to-treat principle. Discussion: It is essential to provide evidence concerning interventions on PC patients with polypharmacy and multimorbidity, conducted in the context of routine clinical practice, and involving young-old patients with significant potential for preventing negative health outcomes. Trial registration: Clinicaltrials.gov, NCT02866799Publisher PDFPeer reviewe

Clonal chromosomal mosaicism and loss of chromosome Y in elderly men increase vulnerability for SARS-CoV-2

The pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID-19) had an estimated overall case fatality ratio of 1.38% (pre-vaccination), being 53% higher in males and increasing exponentially with age. Among 9578 individuals diagnosed with COVID-19 in the SCOURGE study, we found 133 cases (1.42%) with detectable clonal mosaicism for chromosome alterations (mCA) and 226 males (5.08%) with acquired loss of chromosome Y (LOY). Individuals with clonal mosaic events (mCA and/or LOY) showed a 54% increase in the risk of COVID-19 lethality. LOY is associated with transcriptomic biomarkers of immune dysfunction, pro-coagulation activity and cardiovascular risk. Interferon-induced genes involved in the initial immune response to SARS-CoV-2 are also down-regulated in LOY. Thus, mCA and LOY underlie at least part of the sex-biased severity and mortality of COVID-19 in aging patients. Given its potential therapeutic and prognostic relevance, evaluation of clonal mosaicism should be implemented as biomarker of COVID-19 severity in elderly people. Among 9578 individuals diagnosed with COVID-19 in the SCOURGE study, individuals with clonal mosaic events (clonal mosaicism for chromosome alterations and/or loss of chromosome Y) showed an increased risk of COVID-19 lethality